MP14-16 COMBINATION THERAPY FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
2020
INTRODUCTION AND OBJECTIVE:The combination of immune checkpoint inhibitors and antiangiogenics have emerged as a new treatment modality for metastatic renal cell carcinoma (mRCC). Recent randomized...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI